SGLT2i in Diabetic Patients with Renal Transplantation

Post-transplant diabetes mellitus (PTDM), previously known as New Onset Diabetes After Transplantation defined as the diagnosis of diabetes mellitus (DM) in a previously non-diagnosed diabetic person after transplantation. PTDM is a common and serious post-transplant complication that threatens graft survival, increases incidence of infection and development of cardiovascular complications The primary objective of this study is to assess efficacy and safety of dapagliflozin in patients with post-transplantation diabetic patients